ArticleBioImpacts : BI2024

Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model.

Hamed Zare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.